EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $907,000 | -39.5% | 34,325 | +1.7% | 0.08% | -36.4% |
| Q2 2022 | $1,499,000 | -5.9% | 33,738 | +4.8% | 0.13% | +12.8% |
| Q1 2022 | $1,593,000 | -12.4% | 32,183 | -9.9% | 0.12% | 0.0% |
| Q4 2021 | $1,819,000 | -12.4% | 35,719 | -4.0% | 0.12% | -25.0% |
| Q3 2021 | $2,076,000 | +26.6% | 37,219 | -2.9% | 0.16% | +59.2% |
| Q2 2021 | $1,640,000 | +2.1% | 38,319 | -0.4% | 0.10% | -4.9% |
| Q1 2021 | $1,606,000 | +9.7% | 38,465 | +22.3% | 0.10% | -29.5% |
| Q4 2020 | $1,464,000 | +14.2% | 31,444 | +4.2% | 0.15% | +10.6% |
| Q3 2020 | $1,282,000 | -4.5% | 30,189 | +7.8% | 0.13% | -14.8% |
| Q2 2020 | $1,343,000 | +105.7% | 28,000 | +97.2% | 0.16% | +63.2% |
| Q1 2020 | $653,000 | – | 14,200 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |